OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
9,645,728
Share change
-458,922
Total reported value
$100,103,296
Price per share
$10.38
Number of holders
80
Value change
-$12,439,246
Number of buys
38
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q4 2015

As of 31 Dec 2015, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,645,728 shares. The largest 10 holders included Consonance Capital Management LP, FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, and QS Investors, LLC. This page lists 80 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.